Dependence of alpha-synuclein aggregate morphology on solution conditions (Q44129175)

30 November 2017

title

Dependence of alpha-synuclein aggregate morphology on solution conditions (English)

1 reference

30 November 2017

1 reference

1

1 reference

30 November 2017

Thomas Antony

2

1 reference

30 November 2017

Dmitry Cherny

3

1 reference

30 November 2017

Gudrun Heim

4

1 reference

30 November 2017

Thomas M Jovin

5

1 reference

30 November 2017

Vinod Subramaniam

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

Journal of Molecular Biology

30 November 2017

published in

1 reference

30 November 2017

volume

322

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

383-393

1 reference

Alpha-synuclein and neurodegenerative diseases

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Alpha-synuclein in Lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

A Drosophila model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

alpha-Synuclein membrane interactions and lipid specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Membrane binding and self-association of alpha-synucleins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Synucleins in synaptic plasticity and neurodegenerative disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Synthetic filaments assembled from C-terminally truncated alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Evidence for a partially folded intermediate in alpha-synuclein fibril formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Fibrils formed in vitro from alpha-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

PAN, the proteasome-activating nucleotidase from archaebacteria, is a protein-unfolding molecular chaperone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Multiple ligand interaction of alpha-synuclein produced various forms of protein aggregates in the presence of Abeta25-35, copper, and eosin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

The Toxicity of the Alzheimer's β-Amyloid Peptide Correlates with a Distinct Fiber Morphology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Dependence on solution conditions of aggregation and amyloid formation by an SH3 domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

[18] Quantification of β-sheet amyloid fibril structures with thioflavin T

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Yeast prion [psi +] and its determinant, Sup35p

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Study of the "molten globule" intermediate state in protein folding by a hydrophobic fluorescent probe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

A new preparation method for dark-field electron microscopy of biomacromolecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2836%2802%2900775-1

10.1016/S0022-2836(02)00775-1

7 January 2021

Identifiers

DOI

1 reference

30 November 2017

1 reference